You just read:

Innovent provides Update on the Results of Sintilimab for the Treatment of Extranodal NK/T Cell Lymphoma by Oral Presentation at ASCO

News provided by

Innovent Biologics, Inc.

Jun 04, 2019, 20:00 ET